Non-Injectable Insulin Market 2025 to 2034
Non-Injectable Insulin Market 2025 to 2034
Non-Injectable Insulin Market (By Product: Pills, Sprays, Others; By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Drug Stores; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 1.88 Bn
Forecast Year, 2034
USD 5.63 Bn
CAGR, 2025 - 2034
12.99%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global non-injectable insulin market, valued at USD 1.88B in 2025, is projected to reach USD 5.63B by 2034, growing at a CAGR of 12.99%, driven by rising diabetes prevalence, patient preference for oral therapies, and technological advancements.
Non-Injectable Insulin Market Size Analysis
Non-Injectable Insulin Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pills | 0.32 | 0.35 | 0.40 | 0.45 | 0.51 | 0.58 | 0.65 | 0.75 | 0.83 | 0.95 |
| Sprays | 0.63 | 0.71 | 0.80 | 0.90 | 1.02 | 1.16 | 1.31 | 1.47 | 1.66 | 1.88 |
| Others | 0.94 | 1.06 | 1.20 | 1.36 | 1.53 | 1.73 | 1.95 | 2.21 | 2.50 | 2.82 |
Non-Injectable Insulin Market Size By Distribution Channel 2025 to 2034 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 0.31 | 0.36 | 0.40 | 0.46 | 0.51 | 0.59 | 0.65 | 0.74 | 0.83 | 0.95 |
| Online Pharmacies | 0.63 | 0.71 | 0.80 | 0.90 | 1.03 | 1.15 | 1.31 | 1.47 | 1.67 | 1.88 |
| Drug Stores | 0.94 | 1.06 | 1.20 | 1.35 | 1.53 | 1.73 | 1.95 | 2.21 | 2.50 | 2.81 |
Non-Injectable Insulin Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.19 | 0.21 | 0.24 | 0.27 | 0.31 | 0.35 | 0.39 | 0.44 | 0.50 | 0.57 |
| LAMEA | 0.38 | 0.43 | 0.48 | 0.54 | 0.61 | 0.69 | 0.78 | 0.88 | 1.00 | 1.13 |
| Europe | 0.56 | 0.64 | 0.72 | 0.81 | 0.92 | 1.04 | 1.17 | 1.33 | 1.50 | 1.69 |
| Asia-Pacific | 0.75 | 0.85 | 0.96 | 1.08 | 1.22 | 1.38 | 1.57 | 1.77 | 2.00 | 2.26 |
Non-Injectable Insulin Market Size to Hit USD 5.63 Billion by 2034
The global non-injectable insulin market size is evaluated at USD 1.88 billion in 2025 and is expected to grow around USD 5.63 billion by 2034 with a registering a CAGR of 12.99%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
